Steer clear of coadministration with sensitive CYP3A substrates. If coadministration unavoidable, keep track of for adverse reactions and minimize CYP3A substrate dose in accordance with products labeling.Respiratory and cardiovascular status; CBC and urinalysis periodically through prolonged use; daytime alertness; behavior profiletelotristat ethy